Viewing StudyNCT05909618



Ignite Creation Date: 2024-05-06 @ 7:07 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05909618
Status: RECRUITING
Last Update Posted: 2023-11-28
First Post: 2023-05-01

Brief Title: Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Sponsor:
Organization: Sheba Medical Center